<DOC>
	<DOCNO>NCT02914509</DOCNO>
	<brief_summary>To evaluate safety IOP lower efficacy OTX-TP , sustain release travoprost drug product , place canaliculus eyelid treatment subject open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Study Evaluating OTX-TP OAG OH</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Documented diagnosis ocular hypertension open angle Schaffer Grade 3 great openangle glaucoma without pseudoexfoliation pigment dispersion evidence traumatic angle recession . Punctum size small 0.4 mm great 0.9 mm either eye measure use standard punctum gauge . Known suspected allergy and/or hypersensitivity Travoprost prostaglandin , fluorescein , component study product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>